Intermountain Health Launches New Biotech Company

Intermountain Health, a Utah-based, not-for-profit system of 33 hospitals, health plans and a medical group, has launched a new biotechnology company, Culmination Bio, HealthExec reports.

The company will develop an exclusive, anonymized and de-identified intelligence platform that will aim to develop novel clinical insights, discoveries and care processes, according to Intermountain. The precision medicine play will work on a multi-modal intelligence platform that will give customers access to omics-level data and a powerful insights engine for medical research, health data and healthcare services. The aim of the biotech company is to “transform healthcare by providing comprehensive information on patient predisposition to disease, disease prevention and personalized intervention and treatments,” the company said. Read more.

Total
0
Shares
Related Posts
Read More

Flagler Health+ Mulling Potential Merger

“We recognize changes in healthcare and the growth of our community demand that we do more and be more for the people we serve,” said Flagler Health+ CEO Carlton DeVooght.
Read More

Walmart Expands Healthcare Reach

The move marks more direct competition with other retail healthcare providers, such as One Medical and CVS Health that have already been partnering with health systems. Additionally, Walmart has been linked to the potential purchase of ChenMed, a chain of primary care clinics.